Individual Study / FMC

Finnish Maternity Cohort Serum Bank

Finnish Maternity Cohort Serum Bank

Initiatives -
Use of the FMC enables follow-up and longitudinal research of risk factors and biomarkers associated to a disease of interest in the mother or in the child born after the pregnancy in question.
Start Year
1983
Supplementary Information
https://dceg.cancer.gov/news-events/events/dceg-seminar-surcel#:~:text=The%20Finnish%20Maternity%20Cohort%20(FMC,and%20the%20Medical%20Birth%20Register.
Visit FMC

Members

Download
Investigators Contacts
  • Dr. Prof. Heljä-Marja Surcel
    Oulu University

Design

Study design
Population cohort
Supplementary Information
https://pubmed.ncbi.nlm.nih.gov/29071810/

Marker Paper

Lehtinen M, Surcel HM, Natunen K, Pukkala E, Dillner J. Cancer Registry follow-up for 17 million person-years of a nationwide maternity cohort. Cancer Med. 2017 Dec;6(12):3060-3064. doi: 10.1002/cam4.1222

PUBMED 29071810

Recruitment

Sources of Recruitment
  • Individuals

Number of participants

Number of participants
2,000,000
Number of participants with biosamples
Supplementary Information
Women

Access

Availability of data and biosamples

Data
Biosamples
Other